Novo Nordisk to Invest $1.2 Billion in Rare Disease Drug Facility
Novo Nordisk invests $1.2 billion in a new Danish facility dedicated to rare disease treatments. The Odense factory, slated for completion in 2027, will create 400 permanent jobs and boost production capacity.
Novo Nordisk to Invest $1.2 Billion in Rare Disease Drug Facility Read More »